Seres Therapeutics Statistics
Total Valuation
MCRB has a market cap or net worth of $150.72 million. The enterprise value is $188.33 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MCRB has 9.05 million shares outstanding. The number of shares has increased by 19.92% in one year.
| Current Share Class | 9.05M |
| Shares Outstanding | 9.05M |
| Shares Change (YoY) | +19.92% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 8.91% |
| Float | 6.75M |
Valuation Ratios
The trailing PE ratio is 26.91.
| PE Ratio | 26.91 |
| Forward PE | n/a |
| PS Ratio | 429.39 |
| Forward PS | n/a |
| PB Ratio | 3.34 |
| P/TBV Ratio | 3.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 34.91 |
| EV / Sales | 536.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 1.95.
| Current Ratio | 2.30 |
| Quick Ratio | 2.16 |
| Debt / Equity | 1.95 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 15.95% and return on invested capital (ROIC) is -52.45%.
| Return on Equity (ROE) | 15.95% |
| Return on Assets (ROA) | -40.12% |
| Return on Invested Capital (ROIC) | -52.45% |
| Return on Capital Employed (ROCE) | -85.45% |
| Revenue Per Employee | $3,408 |
| Profits Per Employee | $52,369 |
| Employee Count | 103 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.71% in the last 52 weeks. The beta is 0.19, so MCRB's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +1.71% |
| 50-Day Moving Average | 18.13 |
| 200-Day Moving Average | 14.06 |
| Relative Strength Index (RSI) | 46.49 |
| Average Volume (20 Days) | 320,231 |
Short Selling Information
The latest short interest is 925,479, so 10.23% of the outstanding shares have been sold short.
| Short Interest | 925,479 |
| Short Previous Month | 984,687 |
| Short % of Shares Out | 10.23% |
| Short % of Float | 13.70% |
| Short Ratio (days to cover) | 9.67 |
Income Statement
In the last 12 months, MCRB had revenue of $351,000 and earned $5.39 million in profits. Earnings per share was $0.62.
| Revenue | 351,000 |
| Gross Profit | -14.15M |
| Operating Income | -103.43M |
| Pretax Income | 5.39M |
| Net Income | 5.39M |
| EBITDA | -99.17M |
| EBIT | -103.43M |
| Earnings Per Share (EPS) | $0.62 |
Full Income StatementBalance Sheet
The company has $47.64 million in cash and $85.25 million in debt, giving a net cash position of -$37.62 million or -$4.16 per share.
| Cash & Cash Equivalents | 47.64M |
| Total Debt | 85.25M |
| Net Cash | -37.62M |
| Net Cash Per Share | -$4.16 |
| Equity (Book Value) | 43.70M |
| Book Value Per Share | 4.99 |
| Working Capital | 29.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.06 million and capital expenditures -$313,000, giving a free cash flow of -$23.37 million.
| Operating Cash Flow | -23.06M |
| Capital Expenditures | -313,000 |
| Free Cash Flow | -23.37M |
| FCF Per Share | -$2.58 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -29,466.95% |
| Pretax Margin | 1,536.75% |
| Profit Margin | 1,536.75% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MCRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.92% |
| Shareholder Yield | -19.92% |
| Earnings Yield | 3.58% |
| FCF Yield | -15.50% |
Analyst Forecast
The average price target for MCRB is $14.33, which is -13.99% lower than the current price. The consensus rating is "Hold".
| Price Target | $14.33 |
| Price Target Difference | -13.99% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on April 22, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
MCRB has an Altman Z-Score of -10.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.74 |
| Piotroski F-Score | 2 |
